• Markets
  • icon
  • Companies
OPT · ASX

Opthea Limited (ASX:OPT)

AU$0.63

 -0.04 (-5.97%)
ASX:Live
17/05/2024 04:10:34 PM
HALO Ords HALO Momentum HALO Consensus Value HALO Capital Efficiency GROWTH AUS +2
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

OPT Overview

OPT Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

About OPT

Telephone

Address

Description

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

OPT Price Chart

Key Stats

Market Cap

AU$444.08M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.31 - 0.81

Trade Value (12mth)

AU$83,453.00

1 week

-7.35%

1 month

0%

YTD

11.5%

1 year

-3.14%

All time high

3.9120800495147705

Key Fundamentals

EPS 3 yr Growth

611.700%

EBITDA Margin

%

Operating Cashflow

-$179m

Free Cash Flow Return

-586.90%

ROIC

-693.50%

Interest Coverage

-11.20

Quick Ratio

5.20

Other Data

Shares on Issue (Fully Dilluted)

593m

HALO Sector

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.29

OPT Announcements

Latest Announcements

Date Announcements

01 May 24

Opthea Announces Presentations at Retina World Congress

×

Opthea Announces Presentations at Retina World Congress

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

26 April 24

Opthea Presents at the OIS Retina Innovation Summit at ARVO

×

Opthea Presents at the OIS Retina Innovation Summit at ARVO

15 April 24

Notification regarding unquoted securities - OPT

×

Notification regarding unquoted securities - OPT

15 April 24

Notification regarding unquoted securities - OPT

×

Notification regarding unquoted securities - OPT

09 April 24

Opthea Appoints John Han, PharmD, as VP Medical Affairs

×

Opthea Appoints John Han, PharmD, as VP Medical Affairs

05 April 24

Opteha to Participate in the 23rd Needham Virtual Conference

×

Opteha to Participate in the 23rd Needham Virtual Conference

05 April 24

Opthea Corporate Presentation - April 2024

×

Opthea Corporate Presentation - April 2024

04 April 24

Opthea Key Opinion Leader Even on Sozinibercept

×

Opthea Key Opinion Leader Even on Sozinibercept

04 April 24

Opthea Appoints Sujal Shah to the Board of Directors

×

Opthea Appoints Sujal Shah to the Board of Directors

04 April 24

Initial Director's Interest Notice Sujal Shah

×

Initial Director's Interest Notice Sujal Shah

04 April 24

Final Director's Interest Notice DS

×

Final Director's Interest Notice DS

02 April 24

Notification regarding unquoted securities - OPT

×

Notification regarding unquoted securities - OPT

19 March 24

Opthea to Host Key Opinion Leader Event on April 3, 2024

×

Opthea to Host Key Opinion Leader Event on April 3, 2024

06 March 24

Opthea to Participate in Leerink Global Biopharma Conference

×

Opthea to Participate in Leerink Global Biopharma Conference

04 March 24

Opthea Corporate Presentation - March 2024

×

Opthea Corporate Presentation - March 2024

01 March 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

01 March 24

Change of Director's Interest Notice Update

×

Change of Director's Interest Notice Update

29 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

29 February 24

Opthea Reports Half-Year Results and Business Update

×

Opthea Reports Half-Year Results and Business Update

20 February 24

Opthea Appoints Arshard M Khanani as Chief Medical Advisor

×

Opthea Appoints Arshard M Khanani as Chief Medical Advisor

15 February 24

Opthea Completes Enrollment in First Trial of Sozinibercept

×

Opthea Completes Enrollment in First Trial of Sozinibercept

02 February 24

Opthea Strengthens Team with Key Clinical & Regulatory Hires

×

Opthea Strengthens Team with Key Clinical & Regulatory Hires

27 December 23

Opthea to Receive US$35M Commitment and Additional US$50M

×

Opthea to Receive US$35M Commitment and Additional US$50M

OPT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.19 -0.36 -0.45 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.19 -0.36 -0.45 Lock Lock Lock
     Growth % Lock Lock Lock Lock -199.2 -91.9 -23.9 Lock Lock Lock
     PE X Lock Lock Lock Lock 953.6 N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 3.1 N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.11 -0.34 -0.40 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.19 -0.28 -0.38 Lock Lock Lock
     Growth % Lock Lock Lock Lock -243.8 -199.6 -19.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -14.3 -25.4 -73.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.51 0.20 -0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.51 0.20 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 113.2 -61.4 -109.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 320 352 470 Lock Lock Lock
Basic m Lock Lock Lock Lock 320 352 470 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.6 35.9 28.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 53 133 223 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -53 -133 -223 Lock Lock Lock
     Growth % Lock Lock Lock Lock -109.6 -151.1 -67.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -57,660.0 -106,489.5 -138,554.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -53 -133 -223 Lock Lock Lock
     Growth % Lock Lock Lock Lock -109.0 -150.6 -67.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -57,815.4 -106,576.0 -138,647.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -67 -137 -221 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -7 -9 -9 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -61 -128 -212 Lock Lock Lock
     Growth % Lock Lock Lock Lock -267.8 -110.6 -65.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -66,087.3 -102,353.7 -131,469.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -61 -98 -179 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 157 0 249 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -61 -98 -179 Lock Lock Lock
     Growth % Lock Lock Lock Lock -594.9 -61.1 -82.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -664.0 -786.8 -1,112.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 157 65 134 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 184 87 148 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -157 -65 -134 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 18 157 Lock Lock Lock
Equity $m Lock Lock Lock Lock 180 70 -9 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 180 70 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 177.5 -61.3 -112.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -33.0 -146.6 -143.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -33.7 -183.4 2,409.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -43.3 -106.6 -729.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -49.6 -102.4 -693.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -49.8 -78.7 -586.9 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A -11.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.0 0.5 0.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -87.3 -93.0 1,520.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 44.5 5.0 5.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 44.5 5.0 5.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 85.6 74.5 90.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -1,475.6 -561.7 -636.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 3,501.1 13,260.1 16,632.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -73,285.4 -109,300.2 -136,936.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -36.6 -156.5 -148.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -33.0 -146.6 -143.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.0 1.3 -16.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -33.7 -183.4 2,409.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -33.7 -183.4 2,409.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 32,131.2 24,682.5 21,962.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 32,131.2 24,682.5 21,962.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 32,131.2 24,682.5 21,962.4 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.29%

Value ($M)

1

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

-0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

OPT Shortsell

Frequently Asked Questions

The current share price of Opthea Limited (OPT:ASX) is AU$0.63.
The 52-week high share price for Opthea Limited (OPT:ASX) is AU$0.81.
The 52-week low share price for Opthea Limited (OPT:ASX)? is AU$0.31.
Opthea Limited (OPT:ASX) does not pay a dividend.
The last dividend payment of Opthea Limited (OPT:ASX) is AU$1.15.
Opthea Limited (OPT:ASX) has a franking level of 0.0%.
Opthea Limited (OPT:ASX) is classified in the Healthcare.
The current P/E ratio for Opthea Limited (OPT:ASX) is .